Heartland Regional Medical Ctr

Name :

Heartland Regional Medical Ctr

Address  :

5325 Faraon Street

Town  :

Saint Joseph

State  :

Missouri

Country  :

USA

Post Code:

64506

Phone  :

816 271 6000

Web URL  :



Contact Of : Heartland Regional Medical Ctr
Phone Number : To View Details Please Register
Department : Acute Rehabilitation
Phone Number : To View Details Please Register
Department : Adult Infectious Diseases
Phone Number : To View Details Please Register
Department : Cancer Center
Phone Number : To View Details Please Register
Department : Care Management
Phone Number : To View Details Please Register
Department : Center for Pain Management
Phone Number : To View Details Please Register
Department : Laboratory
Phone Number : To View Details Please Register
Department : Heartland Wound Care Center
Phone Number : To View Details Please Register
Department : Outpatient Rehabilitation
Phone Number : To View Details Please Register
Department : Palliative Care Consultation Team
Phone Number : To View Details Please Register
Department : Palliative Care Consultation Team
Phone Number : To View Details Please Register
Department : Regional Development
Name : Marcy George
Phone Number : To View Details Please Register
Department : Community Relations Coordinator at Heartland Healt
Email : To View Details Please Register
Name : Lowell C. Kruse
Designation : President & CEO, Heartland Health
Name : Curt Kretzinger
Designation : Chief Operating Officer
Name : Rudy Wacker
Designation : Chief Administrative Officer
Name : Robert Permut
Designation : Chief Medical Officer
Name : Dirck Clark
Designation : Chief Business Development

CDC Autism is more common than previously thought

New research showing one in 88 US children have autism spectrum disorders is focusing national attention on the need for earlier diagnosis and treatment especially in rural and minority communities Figures released Thursday by the Centers for Disease Control and Prevention show a 23 increase in autism spectrum cases from 2006 to 2008 and 78 incr... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More